Insider Transactions in Q1 2023 at Jounce Therapeutics, Inc. (JNCE)
Insider Transaction List (Q1 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 14
2023
|
Tang Kevin C Director |
BUY
Open market or private purchase
|
Indirect |
20,286
+0.38%
|
$20,286
$1.02 P/Share
|
|
Mar 13
2023
|
Tang Kevin C Director |
BUY
Open market or private purchase
|
Indirect |
65,701
+1.23%
|
$0
$0.99 P/Share
|
|
Jan 10
2023
|
Kimberlee C Drapkin President, CFO and Treasurer |
SELL
Open market or private sale
|
Direct |
7,781
-10.54%
|
$7,781
$1.12 P/Share
|
|
Jan 10
2023
|
Richard /Ca/ Murray Director |
SELL
Open market or private sale
|
Direct |
24,879
-9.84%
|
$24,879
$1.12 P/Share
|
|
Jan 10
2023
|
Elizabeth Trehu Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
5,126
-4.72%
|
$5,126
$1.12 P/Share
|
|
Jan 10
2023
|
Hugh M Cole Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
9,182
-7.7%
|
$9,182
$1.12 P/Share
|
|
Jan 09
2023
|
Kimberlee C Drapkin President, CFO and Treasurer |
SELL
Open market or private sale
|
Direct |
6,315
-7.88%
|
$6,315
$1.1 P/Share
|
|
Jan 09
2023
|
Richard /Ca/ Murray Director |
SELL
Open market or private sale
|
Direct |
20,191
-7.39%
|
$20,191
$1.1 P/Share
|
|
Jan 09
2023
|
Elizabeth Trehu Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
4,159
-3.69%
|
$4,159
$1.1 P/Share
|
|
Jan 09
2023
|
Hugh M Cole Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
7,452
-5.88%
|
$7,452
$1.1 P/Share
|